Method of treating heart failure with preserved ejection fraction by administering milrinone
US10493067B2 · kind B2 · utility
1Cited by
7References
17Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 21, 2015 |
| Grant date | Dec 3, 2019 |
| Priority date | — |
| Expiry date | Dec 21, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods of treating subjects having heart failure with preserved ejection fraction (HFpEF) with a sustained-delivery formulation of cardiotonic 5-(pyridinyl)-2(1H)-pyridinone compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.